Aileron Therapeutics, Inc.ALRNNASDAQ

Revenue (LTM)

Net Income (LTM)

$-63M

-299.7% YoY

Free Cash Flow

$-22M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-0↑25.8%	-0↓39.7%	-0↑29.6%	0
Operating Income	-20	-27↓29.8%	-28↓3.9%	-16↑41.1%	-65↓300.0%
Net Income	-22	-26↓18.1%	-27↓4.8%	-16↑41.8%	-63↓299.7%
EBITDA	-20	-26↓30.3%	-27↓3.8%	-16↑43.2%	-65↓317.0%
EPS Diluted	-12.52	-5.80↑53.7%	-5.95↓2.6%	-3.42↑42.5%	-3.51↓2.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	7	4↓48.9%	5↑44.3%	17↑233.3%	13↓25.7%
Total Current Assets	16	48↑195.1%	22↓54.6%	18↓16.5%	14↓25.2%
Total Assets	16	48↑196.7%	22↓54.6%	106↑381.7%	62↓41.3%
Total Current Liabilities	4	5↑13.8%	3↓24.9%	4↑29.6%	6↑31.1%
Total Liabilities	4	5↑9.5%	3↓26.1%	99↑2829.1%	8↓92.1%
Total Equity	12	44↑261.0%	19↓57.6%	7↓63.0%	54↑689.8%
Total Debt	0	0↓58.1%	0↓79.6%	0↑45.5%	0
Net Debt	-7	-3↑48.4%	-5↓50.1%	-17↓234.5%	-13↑25.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-20	-24↓16.0%	-25↓4.7%	-20↑20.3%	-22↓12.5%
Capital Expenditure	-0	-0↓3040.0%	0	0	0
Free Cash Flow	-20	-24↓16.7%	-25↓4.0%	-20↑20.3%	-22↓12.5%
Stock-Based Comp	2	2↑19.4%	2↓7.8%	1↓42.9%	1↓6.1%
Net Change in Cash	2	-4↓331.4%	2↑139.7%	12↑660.3%	-4↓136.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance